| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.3B | $11.2B | $10.2B | $8.6B | $2.2B | $2.3B | $2.1B | $0.1B |
| Cost of Revenue | $6.9B | $6.8B | $6.2B | $5.3B | $1.4B | $1.5B | $1.4B | $1.3B |
| Gross Profit | $4.4B | $4.4B | $4.0B | $3.4B | $0.8B | $0.8B | $0.7B | $0.7B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.8B | $2.7B | $2.4B | $2.1B | $0.5B | $0.5B | $0.5B | $0.4B |
| Operating Income | $1.6B | $1.7B | $1.6B | $1.3B | $0.2B | $0.3B | $0.3B | $0.3B |
| Net Income | $1.2B | $1.3B | $1.2B | $1.0B | $0.2B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $25.44 | $26.18 | $24.17 | $18.09 | $3.04 | $3.91 | $3.64 | $3.42 |
| EPS (Diluted) | $25.34 | $26.03 | $24.01 | $17.98 | $3.03 | $3.89 | $3.61 | $3.40 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.0B | $5.7B | $5.4B | $4.8B | $5.1B | $4.9B | $3.2B | $2.9B |
| Current Assets | $3.0B | $2.8B | $2.7B | $2.3B | $2.5B | $2.1B | $1.9B | $1.7B |
| Cash & Equivalents | $0.7B | $0.8B | $0.7B | $0.4B | $1.0B | $0.4B | $0.4B | $0.3B |
| Total Liabilities | $3.5B | $3.4B | $3.4B | $3.2B | $3.1B | $3.0B | $1.4B | $1.1B |
| Current Liabilities | $1.8B | $1.7B | $1.7B | $1.6B | $1.3B | $1.1B | $0.8B | $0.6B |
| Stockholders' Equity | $2.5B | $2.3B | $2.0B | $1.5B | $2.0B | $1.9B | $1.8B | $1.8B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $1.5B | $1.5B | $1.1B | $0.8B | $1.1B | $1.0B | $0.8B |
| Investing Cash Flow | $-0.4B | $-0.4B | $-0.3B | $-0.2B | $-0.0B | $-0.5B | $-0.2B | $-0.5B |
| Capital Expenditures | $0.4B | $0.4B | $0.3B | $0.2B | $0.2B | $0.3B | $0.3B | $0.4B |
| Financing Cash Flow | $-1.0B | $-1.0B | $-0.9B | $-1.5B | $-0.1B | $-0.6B | $-0.6B | $-0.4B |